Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBRX | FORTE BIOSCIENCES INC | $373.93M | $29.85 | $67.00 | 124.46% | Strong Buy | 3 | N/A | N/A | -84.07% | -72.82% | |||
| CEVA | CEVA INC | $540.64M | $22.51 | $34.33 | 52.52% | Strong Buy | 3 | 14.72% | N/A | 10.12% | 8.89% | |||
| AKA | AKA BRANDS HOLDING CORP | $120.07M | $11.18 | $24.33 | 117.65% | Strong Buy | 3 | N/A | N/A | -12.35% | -3.31% | |||
| CGTX | COGNITION THERAPEUTICS INC | $109.46M | $1.24 | $3.33 | 168.79% | Strong Buy | 3 | N/A | N/A | -135.57% | -114.12% | |||
| CRVO | CERVOMED INC | $49.96M | $5.40 | $22.80 | 322.22% | Strong Buy | 5 | -42.61% | N/A | -25.64% | -21.79% | |||
| KYMR | KYMERA THERAPEUTICS INC | $5.12B | $71.16 | $118.67 | 66.76% | Strong Buy | 18 | 1.82% | N/A | -33.08% | -28.40% | |||
| CSTL | CASTLE BIOSCIENCES INC | $1.15B | $39.51 | $48.00 | 21.49% | Strong Buy | 5 | 7.65% | N/A | -0.32% | -0.26% | |||
| ZGN | ERMENEGILDO ZEGNA NV | $2.25B | $8.86 | $11.70 | 32.05% | Strong Buy | 3 | -0.82% | N/A | 15.01% | 4.87% | |||
| ABVX | ABIVAX SA | $8.31B | $113.98 | $140.00 | 22.83% | Strong Buy | 9 | N/A | N/A | N/A | N/A | |||
| HELP | CYBIN INC | $164.23M | $7.13 | $49.33 | 591.91% | Strong Buy | 3 | N/A | N/A | -51.47% | -39.47% | |||
| TYRA | TYRA BIOSCIENCES INC | $1.66B | $31.08 | $40.60 | 30.63% | Strong Buy | 5 | N/A | N/A | -7.76% | -7.21% | |||
| CLFD | CLEARFIELD INC | $414.20M | $29.93 | $43.50 | 45.34% | Strong Buy | 4 | 11.85% | N/A | 7.08% | 5.92% | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $188.91M | $6.35 | $11.67 | 83.73% | Strong Buy | 6 | N/A | N/A | N/A | N/A | |||
| IMTX | IMMATICS NV | $1.18B | $9.70 | $22.33 | 130.24% | Strong Buy | 3 | 4.43% | N/A | -23.13% | -18.59% | |||
| MBX | MBX BIOSCIENCES INC | $1.61B | $35.83 | $56.00 | 56.29% | Strong Buy | 9 | N/A | N/A | -38.17% | -36.98% | |||
| SPWH | SPORTSMAN's WAREHOUSE HOLDINGS INC | $55.41M | $1.44 | $2.58 | 79.38% | Strong Buy | 3 | 0.82% | N/A | -8.43% | -1.93% | |||
| SLDB | SOLID BIOSCIENCES INC | $510.31M | $6.55 | $13.17 | 101.02% | Strong Buy | 6 | N/A | N/A | -4.67% | -3.71% | |||
| CRVS | CORVUS PHARMACEUTICALS INC | $1.53B | $20.54 | $32.25 | 57.01% | Strong Buy | 4 | N/A | N/A | 19.81% | 17.67% | |||
| TERN | TERNS PHARMACEUTICALS INC | $3.09B | $34.26 | $48.60 | 41.87% | Strong Buy | 9 | N/A | N/A | -43.99% | -41.42% | |||
| CGEM | CULLINAN THERAPEUTICS INC | $700.05M | $11.85 | $31.75 | 167.93% | Strong Buy | 4 | N/A | N/A | -41.65% | -38.83% | |||
| CBC | CENTRAL BANCOMPANY INC | N/A | $24.06 | $28.88 | 20.01% | Strong Buy | 4 | N/A | N/A | 14.17% | 2.43% | |||
| GHI | GREYSTONE HOUSING IMPACT INVESTORS LP | $181.82M | $7.71 | $11.67 | 51.32% | Strong Buy | 3 | N/A | N/A | 4.74% | 0.93% | |||
| NRIX | NURIX THERAPEUTICS INC | $1.84B | $17.87 | $30.13 | 68.58% | Strong Buy | 8 | 11.55% | N/A | -37.00% | -28.96% | |||
| ORIC | ORIC PHARMACEUTICALS INC | $1.07B | $10.98 | $20.20 | 83.97% | Strong Buy | 10 | N/A | N/A | -36.31% | -34.27% | |||
| TRVI | TREVI THERAPEUTICS INC | $1.35B | $10.51 | $20.78 | 97.70% | Strong Buy | 9 | N/A | N/A | -18.40% | -17.52% | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.69B | $24.57 | $41.14 | 67.45% | Strong Buy | 7 | N/A | N/A | -47.37% | -41.33% | |||
| UPB | UPSTREAM BIO INC | $1.64B | $30.43 | $46.00 | 51.17% | Strong Buy | 3 | 19.28% | N/A | -61.63% | -59.64% | |||
| OKLO | OKLO INC | $14.75B | $94.39 | $127.09 | 34.64% | Strong Buy | 11 | N/A | N/A | -4.21% | -4.07% | |||
| NTSK | NETSKOPE INC | $6.33B | $16.10 | $26.77 | 66.27% | Strong Buy | 13 | N/A | N/A | 0.23% | 0.02% | |||
| LUCK | LUCKY STRIKE ENTERTAINMENT CORP | $1.14B | $8.17 | $12.67 | 55.04% | Strong Buy | 3 | 5.57% | N/A | N/A | N/A | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $34.66M | $0.71 | $4.67 | 553.64% | Strong Buy | 3 | N/A | N/A | -216.51% | -80.52% | |||
| IDYA | IDEAYA BIOSCIENCES INC | $2.95B | $33.65 | $50.18 | 49.13% | Strong Buy | 11 | -0.03% | N/A | -6.61% | -6.09% | |||
| GHRS | GH RESEARCH PLC | $996.19M | $16.06 | $35.75 | 122.60% | Strong Buy | 4 | N/A | N/A | -36.04% | -34.78% | |||
| NAVN | NAVAN INC | $3.37B | $13.57 | $24.80 | 82.76% | Strong Buy | 10 | N/A | N/A | 2.28% | 1.55% | |||
| RAPP | RAPPORT THERAPEUTICS INC | $1.26B | $26.44 | $52.75 | 99.51% | Strong Buy | 4 | N/A | N/A | -33.19% | -31.72% | |||
| AIRG | AIRGAIN INC | $52.62M | $4.40 | $6.00 | 36.36% | Strong Buy | 3 | 12.80% | N/A | N/A | N/A | |||
| KYTX | KYVERNA THERAPEUTICS INC | $367.01M | $8.38 | $26.00 | 210.26% | Strong Buy | 3 | N/A | N/A | -123.19% | -100.01% | |||
| CBIO | CRESCENT BIOPHARMA INC | $149.07M | $10.73 | $28.67 | 167.17% | Strong Buy | 3 | N/A | N/A | -62.63% | -52.83% | |||
| T | AT&T INC | $170.64B | $24.07 | $29.70 | 23.39% | Strong Buy | 10 | 2.64% | -4.00% | 19.09% | 4.99% | |||
| ACRV | ACRIVON THERAPEUTICS INC | $59.64M | $1.89 | $11.67 | 517.30% | Strong Buy | 3 | N/A | N/A | -38.36% | -33.95% | |||
| ANRO | ALTO NEUROSCIENCE INC | $476.25M | $15.33 | $28.17 | 83.74% | Strong Buy | 6 | N/A | N/A | -58.37% | -44.30% | |||
| APGE | APOGEE THERAPEUTICS INC | $4.83B | $70.69 | $102.71 | 45.30% | Strong Buy | 7 | N/A | N/A | -56.07% | -52.51% | |||
| CYRX | CRYOPORT INC | $489.67M | $9.78 | $14.10 | 44.17% | Strong Buy | 5 | 5.90% | N/A | -1.29% | -0.86% | |||
| CTMX | CYTOMX THERAPEUTICS INC | $999.67M | $5.90 | $8.50 | 44.07% | Strong Buy | 6 | -23.00% | N/A | -40.23% | -27.30% | |||
| WYFI | WHITEFIBER INC | $847.84M | $22.16 | $34.38 | 55.12% | Strong Buy | 8 | N/A | N/A | 5.15% | 4.46% | |||
| PEPG | PEPGEN INC | $358.87M | $5.22 | $11.50 | 120.31% | Strong Buy | 4 | N/A | N/A | 11.61% | 9.96% | |||
| DNLI | DENALI THERAPEUTICS INC | $3.06B | $20.84 | $28.60 | 37.24% | Strong Buy | 5 | N/A | N/A | -11.27% | -9.89% | |||
| KSCP | KNIGHTSCOPE INC | $42.58M | $3.70 | $16.67 | 350.46% | Strong Buy | 3 | N/A | N/A | -116.82% | -76.52% | |||
| CLYM | CLIMB BIO INC | $351.83M | $5.16 | $9.33 | 80.87% | Strong Buy | 3 | N/A | N/A | -57.76% | -56.08% | |||
| IMRX | IMMUNEERING CORP | $322.85M | $5.00 | $19.00 | 280.00% | Strong Buy | 4 | N/A | N/A | -16.85% | -15.94% | |||
| MRP | MILLROSE PROPERTIES INC | $4.91B | $29.56 | $39.33 | 33.06% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| RLMD | RELMADA THERAPEUTICS INC | $289.67M | $3.95 | $9.00 | 127.85% | Strong Buy | 3 | N/A | N/A | -861.36% | -548.07% | |||
| TTAN | SERVICETITAN INC | $8.58B | $91.57 | $137.36 | 50.00% | Strong Buy | 14 | 11.20% | N/A | N/A | N/A | |||
| BIOA | BIOAGE LABS INC | $699.53M | $19.51 | $33.33 | 70.85% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| CADL | CANDEL THERAPEUTICS INC | $315.12M | $5.74 | $17.25 | 200.52% | Strong Buy | 4 | N/A | N/A | N/A | N/A | |||
| CRC | CALIFORNIA RESOURCES CORP | $4.26B | $50.88 | $64.67 | 27.10% | Strong Buy | 6 | 0.46% | 2.82% | 10.17% | 5.18% | |||
| JBIO | JADE BIOSCIENCES INC | $719.51M | $15.64 | $22.60 | 44.50% | Strong Buy | 5 | N/A | N/A | -54.04% | -47.87% | |||
| MGX | METAGENOMI INC | $60.07M | $1.60 | $10.00 | 525.00% | Strong Buy | 3 | -18.24% | N/A | -29.75% | -21.41% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.